Wanqin Zeng

机构：University of Electronic Science and Technology of China, Sichuan University, Sichuan Cancer Hospital

发表论文 22 篇 · 总被引 367 次 · h-index 6

代表论文

• Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment (2024 · Nature Nanotechnology · 被引 167)
• Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response (2021 · Cell Host & Microbe · 被引 139)
• IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis (2025 · Circulation · 被引 17)
• DEMINERS enables clinical metagenomics and comparative transcriptomic analysis by increasing throughput and accuracy of nanopore direct RNA sequencing (2025 · Genome biology · 被引 14)
• Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors (2024 · Molecular Cancer Therapeutics · 被引 11)
• Short-read and long-read RNA sequencing of mouse hematopoietic stem cells at bulk and single-cell levels (2021 · Scientific Data · 被引 6)